World News | Reuters | Wednesday December 7, 2016
Britain's competition watchdog said on Wednesday it had fined Pfizer a record 84.2 million pounds ($106.54 million) for ramping up the cost of an epilepsy drug by as much as 2,600 percent.
www.ndtv.com